2004
DOI: 10.1016/j.brainresbull.2004.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Increased urinary F2-isoprostanes levels in the patients with Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2005
2005
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(23 citation statements)
references
References 23 publications
0
23
0
Order By: Relevance
“…However, the reasons for greater baseline F2-IsoPs in healthy children from those studies and ours compared with healthy adults10,11 are unclear. Higher levels of IsoPs increase were reported in moderately trained or untrained exercising adults29 as compared with trained adults,12 suggesting a role training status may play in IsoPs response to exercise.…”
Section: Discussionmentioning
confidence: 64%
See 1 more Smart Citation
“…However, the reasons for greater baseline F2-IsoPs in healthy children from those studies and ours compared with healthy adults10,11 are unclear. Higher levels of IsoPs increase were reported in moderately trained or untrained exercising adults29 as compared with trained adults,12 suggesting a role training status may play in IsoPs response to exercise.…”
Section: Discussionmentioning
confidence: 64%
“…Their urinary excretion provides an index of nonenzymatic lipid peroxidation,8 with 8-isoprostaglandin F 2 α being one of the most often studied F 2 -IsoPs in protocols involving human research. Such a high interest was largely driven by the fact that urinary excretion of 8-isoprostaglandin F 2 α was found in conditions associated with elevated oxidative stress, including overweight or obesity,9 atherosclerosis,7 type 2 diabetes,10 and neurodegenerative diseases 11…”
mentioning
confidence: 99%
“…These is, therefore, important evidence that support the importance of 8-OHdG as a biomarker to complement NDDs diagnosis, and a faster methodology using MEPS/UHPLC-UV has been already described [90,110]. Regarding F2-isoprostanes as biomarkers of oxidative stress, unlike the CVDs ([105] and references within, [106,107]) and ODs [119], there are conflicting results about their role as biomarkers in different NDDs, such as AD, PD, ALS or Huntington’s diseases [124,125,126,127,128,129,130]. This inconsistency is probably due to the inability of some of the methodologies developed to differentiate between the several isoprostane isoforms, originating misleading results that need to be clarified with further studies.…”
Section: Metabolic Profiling Of Urine: Recent Trendsmentioning
confidence: 99%
“…With regard to AD, some studies have shown increased F2-isoprostane levels in plasma or urine of AD patients compared to age-matched controls [25-27], however these findings remain controversial [28-30]. In addition, increased CSF levels of F 2 -isoprostanes have also been shown in AD patients [25,28,31-33], which, importantly, can be suppressed by antioxidant treatment [34].…”
Section: Introductionmentioning
confidence: 99%